Answer
During treatment with ALTUVOCT 500 IU (efanesoctocog alfa), using Actin-FS instead of Actin-FSL in a one-stage clotting assay gives approximately 2.5-fold higher measured plasma factor VIII activity, according to a field study.
Sources for this answer
- ALTUVOCT 500 IU powder and solvent for solution for injectionSwedish Orphan Biovitrum Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked